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The CH 2 Cl 2 /Me 2 CO-soluble portion was subjected to silica gel column chromatography eluted with solvent systems of n-hexaneMe 2 CO [20:1 (fr. 1-30), 10:1 (fr. 31-39), 5:1 (fr. 40-49)], CH 2 Cl 2 Me 2 CO [10:1 (fr. 50-55), 5:1 (fr. 56-60)], and CH 2 Cl 2 MeOH [10:1 (fr. 61-73), 5:1 (fr. 74-81), 0:1 (fr. 82-85)] to yield 85 fractions (3 L each), which were combined to afford the pooled fractions C-1 ~ C-26. C-1 (fr.1) and C-5 (fr. 5) were re-crystallized from n-hexane to give 4 (8.7 mg) and 5 (23.7 mg). C-7 (fr. 13-15) was separated again over a silica gel column (230-400 mesh, 2.5  60 cm; Merck), which was eluted with n-hexaneCH 2 Cl 2 (1:1 and 1:5) to yield 6 (17.4 mg). Chromatography of C-11 (fr. 34-36) over a silica gel column eluted with nhexaneCH 2 Cl 2 /5:1~1:10 afforded 15 fractions (C-11-1~15, 200 mL each). C-11-7~11
and C-11-12~15 were separately purified by preparative silica-TLC (nhexaneCH 2 Cl 2 /1:4) to give 8 (5.2 mg) and 2 (3.3 mg). C-20 (fr. 64-65) was separated over a silica gel column eluted with CH 2 Cl 2 MeOH/20:1~5:1. Then, the 5:1 eluate was further purified over a Sephadex LH-20 column (20-100 m, 3  38 cm; GE Healthcare) and was eluted with MeOHH 2 O/3:1 to yield 11 (14.7 mg). Compounds 7 (2.6 mg) and 9 (4.7 mg) were obtained following purification of C-22 (fr. 69-73) over a Sephadex LH-20 column, which was eluted with MeOHH 2 O/3:1. Moreover, the The anti-inflammatory activity of 1 and 3 on LPS-induced NO production was assayed with a method described previously [11] . Aminoguanidine used as a positive control was purchased from Sigma-Aldrich with a purity of 98%. The purities of 1 and 3 were > 98% as determined by HPLC with an UV detector (254 nm). 
